ALPHA (psychedelic)
 | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(1,3-benzodioxol-5-yl)propan-1-amine | |
| Clinical data | |
| Routes of administration | Oral |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| CAS Number | 127292-42-6 |
| ATC code | none |
| ChemSpider |
11853242  |
| Chemical data | |
| Formula | C10H13NO2 |
| Molar mass | 179.216 g/mol |
| |
| |
| (verify) | |
ALPHA or alpha-ethyl-3,4-methylenedioxybenzylamine, is a lesser-known psychedelic drug and a substituted benzylamine. It is also the benzylamine analogue of MDA. ALPHA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved) in the MDA page, the threshold dosage is listed as 10 mg. At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling. This compound is not anoretic at any dose. It lasts about 3 hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.
See also
External links
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.